Transcode Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Transcode Therapeutics shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Transcode Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Transcode Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Transcode Therapeutics by Citadel Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $47k | 282k | 0.16 |
Top funds holding Transcode Therapeutics
View all funds holding Transcode Therapeutics